drugset / Trial / NCT06759584

Management of Temporomandibular Disorders (TMD)

NCT06759584 ↗

Completed 80 enrolled Minia University
RandomizedParallel-groupDouble-blindTreatment

Summary

Temporomandibular disorders (TMD) are a group of pathologies of the temporomandibular joint, their muscles, and related structures. It is considered a musculoskeletal disorder of the masticatory system, and it has a 25% prevalence in overall population. In 3% - 7% of the population, pain and dysfunction leads to the need for treatment . The etiology of TMD is multifactorial .

Timeline

Start
2023-04-28
Primary completion
2024-02-20
Completion
2024-02-28

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexamethasone Small molecule — Topical